|
⚲
|
| Keyboard |
| Satlin Andrew
✚
|
|
|---|---|
| CIK # | 0001722858 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001722858] | |
| 4 | [0001722858] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Satlin Andrew | |
| Intra-Cellular Therapies Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intra-Cellular Therapies Inc ITCI
Restricted Stock Units · derivative
|
2020-02-18 | Grant | 33,417 | $0.00 | |
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2020-02-18 | Grant | 26,754 | $0.00 | |
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2020-01-09 | Sell | 11,573 | $26.16 | 302,750 |
|
Intra-Cellular Therapies Inc ITCI
Common Stock
|
2020-01-08 | Option exercise | 22,911 | ||
|
Intra-Cellular Therapies Inc ITCI
Restricted Stock Units · derivative
|
2020-01-08 | Option exercise | 22,911 | $0.00 | |
|
Intra-Cellular Therapies Inc ITCI
Restricted Stock Units · derivative
|
2019-01-08 | Grant | 68,735 | $0.00 | |
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2019-01-08 | Grant | 94,443 | $0.00 | |
|
Intra-Cellular Therapies Inc ITCI
Stock Option (right to buy) · derivative
|
2017-11-13 | Grant | 170,500 | $0.00 |